newsfilter
← Latest News
GlobeNewswire·

Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights

Topline GSBR-1290 Phase 2a 12-week obesity data on track for June 2024 Phase 2b study in obesity expected to begin as planned in the fourth quarter 2024 Plan to initiate dosing in first-in-human Phase 1 clinical trial